The Anti-Cancer Complex is an oncological intravenous formulation developed to target malignant cells, support the body’s innate cancer defence mechanisms and create a systemic environment hostile to cancer proliferation. Its active Oncological Bioactive Complex combines GcMAF — the macrophage-activating factor that stimulates the immune system’s primary cancer-fighting cells — with high-dose Ascorbic Acid, which has been the subject of extensive research into its selective cytotoxicity against malignant cells, and Vitamin B17 (Laetrile), the natural compound whose relationship with cancer cell metabolism has been studied for decades.

Together these three active agents work to stimulate macrophage activity, reduce inflammation, target malignant cell structures and reinforce the body’s own oncological defences. Administered as a 500ml isotonic infusion under clinical supervision, the Anti-Cancer Complex is designed for those who seek a biological approach to cancer defence that works alongside and beyond the limitations of conventional oncology.